<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Choice of anticoagulant therapy for a mechanical prosthetic valve during the 1&lt;sup&gt;st&lt;/sup&gt; trimester of pregnancy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Choice of anticoagulant therapy for a mechanical prosthetic valve during the 1<sup>st</sup> trimester of pregnancy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Choice of anticoagulant therapy for a mechanical prosthetic valve during the 1<sup>st</sup> trimester of pregnancy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm describes choice of anticoagulant therapy for a mechanical prosthetic valve during only the <strong>1<sup>st</sup> trimester</strong> of pregnancy. Refer to UpToDate content on management of antithrombotic therapy during the 2<sup>nd</sup> and 3<sup>rd</sup> trimesters of pregnancy and during the peripartum period. <br/><br/>Use of concomitant aspirin: For pregnant patients with mechanical valves, we recommend low-dose aspirin (75 to 100 mg/day; eg, 81 mg/day) along with anticoagulation with heparin (LMWH or UFH) or VKA. In this setting, some clinicians administer low-dose aspirin only during periods of heparin anticoagulation (LMWH or UFH).<br/></div><div class="graphic_footnotes">VKA: vitamin K antagonist; INR: international normalized ratio; SC LMWH: subcutaneous low molecular weight heparin; UFH: unfractionated heparin; IV: intravenous; aPTT: activated partial thromboplastin time.<br/>* Refer to UpToDate content on the maternal and fetal risks associated with various types of anticoagulants.<br/>¶ Refer to UpToDate content on therapeutic targets for VKA for mechanical prosthetic valves. Although therapeutic VKA therapy during the 1<sup>st</sup> trimester is an option for some clinical settings, some pregnant women in these settings will choose to avoid the fetal risks of VKA therapy and will opt for SC LMWH (administered at least twice daily with anti-Xa monitoring) despite the greater risks of prosthetic valve thrombosis and thromboembolism.<br/>Δ For patients taking high-dose VKA, some clinicians offer the option of continued VKA during the 1<sup>st</sup> trimester after fully informed consent. <br/><font class="lozenge">◊</font> When a decision is made to switch to LMWH, VKA should be discontinued and dose-adjusted SC LMWH started (at least twice daily; along with daily low-dose aspirin) once pregnancy is confirmed and ideally before the 5th week of gestation. A plan should be made prior to conception on how this change in therapy will be performed (including potential hospitalization for close monitoring during the transition). Target anti-Xa activity 1.0 to 1.2 units/mL for mitral valve prosthesis and 0.8 to 1.0 units/mL for aortic valve prosthesis at 4 to 6 hours postdose). We also suggest checking trough activit<em innerhtml="">y </em><span style="COLOR: red"><span style="COLOR: black">30 minutes or less prior to the next dos</span></span><span innerhtml="" style="COLOR: black">e</span> (proposed minimum trough level of 0.6 units/mL), although the efficacy and safety of this approach have not been established. Refer to UpToDate content on administration of LMWH.<br/>§ If LMWH is unavailable due to resource limitations, inpatient dose-adjusted continuous IV infusion of UFH (with targeted aPTT 2 to 2.5 times control <span style="COLOR: black">or anti-Xa activity 0.3 to 0.7 units/mL</span><span style="COLOR: black">)</span> plus low-dose aspirin is a potential option, although the efficacy and safety of this treatment over weeks are uncertain, given difficulties in monitoring IV UFH, the limited efficacy of UFH in this setting, and the risk of infection.</div><div id="graphicVersion">Graphic 129937 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
